---
schema_version: "secwatch.filing_event.v1"
accession: "0001493152-23-037840"
form_type: "8-K"
ticker: "BFRG"
cik: "0001829247"
company_name: "BullFrog AI Holdings, Inc."
filed_at: "2023-10-20T23:59:59+00:00"
generated_at: "2026-06-09T18:54:35.973152+00:00"
event_type: "other_material"
sentiment: "neutral"
materiality_score: 0.4
calibrated_materiality_score: 0.4
confidence: "high"
source: SEC EDGAR
---

# Bullfrog AI enters commercial agreement with Lieber Institute to commercialize AI-derived brain data products

## Summary
- Entered commercial agreement with Lieber Institute for Brain Development to commercialize AI/ML products from LIBD brain data.
- BFAI granted exclusive worldwide license to develop, sell Licensed Products in drug development field (therapeutic, target ID, patient selection).
- BFAI to pay LIBD royalty on Net Sales (rates redacted); exclusivity ends if no First Commercial Sale within 2 years of listing.
- LIBD may change license to non-exclusive after 3 years from First Commercial Sale, adjusting royalty rate.
- LIBD receives Licensed Products free for internal research; if LIBD commercializes, pays BFAI 70% of Net Sales.

## SEC filing metadata
- accession: 0001493152-23-037840
- form_type: 8-K
- ticker: BFRG
- cik: 0001829247
- company_name: BullFrog AI Holdings, Inc.
- filed_at: 2023-10-20T23:59:59+00:00
- event_type: other_material
- sentiment: neutral
- materiality_score: 0.4
- calibrated_materiality_score: 0.4
- confidence: high
- sec_items: 1.01, 9.01
- EDGAR index: https://www.sec.gov/Archives/edgar/data/1829247/000149315223037840/0001493152-23-037840-index.htm
- EDGAR primary document: https://www.sec.gov/Archives/edgar/data/1829247/000149315223037840/form8-k.htm

## Machine-readable alternates
- HTML: https://secwatch.observer/filing/0001493152-23-037840
- JSON: https://secwatch.observer/filing/0001493152-23-037840.json
- Plain text: https://secwatch.observer/filing/0001493152-23-037840.txt

## Key facts
- Material Agreements
  BullFrog AI Holdings, Inc. entered into Commercial Agreement with Lieber Institute for Brain Development (effective 2023-10-16).
  - Action: entry
  - Counterparty: Lieber Institute for Brain Development
  - Effective: 2023-10-16
  source text: Effective October 16, 2023, Bullfrog AI Holdings, Inc. (the “Company”) entered a Commercial Agreement (the “Agreement”) with the Lieber Institute for Brain Development (LDB) engaging in the development and commercialization of AI and machine learning solutions to advance medicine and improve human health.
  evidence_url: https://www.sec.gov/Archives/edgar/data/1829247/000149315223037840/0001493152-23-037840-index.htm

This AI-assisted summary is a reading aid. Review the linked SEC EDGAR filing before relying on any specific claim.